Human Anti-HIV-1 gp160 Recombinant Antibody (clone 10-188) (CAT#: MRO-3675CQ)

Recombinant human antibody to gp160(307-320). 10-188 antibody neutralized 100% of Tier-1 HIV viruses and 19% of Tier-2 HIV viruses tested.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
Neut

Figure 1 Neutralizing activity of HIV-gp120/41 BiAbs.

Figure 1 Neutralizing activity of HIV-gp120/41 BiAbs.

Graph shows neutralization curves of SS1196.1 pseudovirus for 10-188 BiAb and controls. The x axis shows the antibody concentration (nM) required to achieve 50% neutralization (IC50), indicated by the dashed line.

Mouquet, H., Warncke, M., Scheid, J. F., Seaman, M. S., & Nussenzweig, M. C. (2012). Enhanced HIV-1 neutralization by antibody heteroligation. Proceedings of the National Academy of Sciences of the United States of America, 109(3), 875-880.

WB

Figure 2 Design and production of HIV-gp120/41 BiAbs.

Figure 2 Design and production of HIV-gp120/41 BiAbs.

Western blot analyses of gp120/41 BiAbs and BiAb controls (anti-gp120/mGO53 heterodimers).

Mouquet, H., Warncke, M., Scheid, J. F., Seaman, M. S., & Nussenzweig, M. C. (2012). Enhanced HIV-1 neutralization by antibody heteroligation. Proceedings of the National Academy of Sciences of the United States of America, 109(3), 875-880.

ELISA

Figure 3 Design and production of HIV-gp120/41 BiAbs.

Figure 3 Design and production of HIV-gp120/41 BiAbs.

Binding analyses of 10-188 IgG antibody and scFv2-Fc control to gp120 antigen measured by ELISA. The x axis shows the antibody concentration (nM) required to obtain the ELISA values (OD405 nm) indicated on the y axis.

Mouquet, H., Warncke, M., Scheid, J. F., Seaman, M. S., & Nussenzweig, M. C. (2012). Enhanced HIV-1 neutralization by antibody heteroligation. Proceedings of the National Academy of Sciences of the United States of America, 109(3), 875-880.


Specifications

  • Host Species
  • Human
  • Type
  • Human IgG
  • Specificity
  • Recognizes HIV-1 gp160(307-320)
  • Species Reactivity
  • HIV-1
  • Clone
  • 10-188
  • Applications
  • Neut, WB, ELISA

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • This antibody has been reported for use in Western Blot, Neutralization and Enzyme-Linked Immunosorbent Assay.

Target

  • Alternative Names
  • Human immunodeficiency virus type 1; HIV-1; Envelope glycoprotein GP160; gp160; HIV envelope

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 10-188"

See other products for "HIV-1 gp160"

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for MRO-3675CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare